FindTrial
Sign In

An Open-Label, Randomized Crossover Study to investigate the feasibility and applicability of the WatchBP O3 family from Microlife

An Open-Label, Randomized Crossover Study to investigate the feasibility and applicability of the WatchBP O3 family from Microlife - WatchBP study for better diagnosis of hypertension

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33032
Enrollment
71
Registered
2009-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high blood pressure hypertension

Interventions

None listed

Sponsors

Microlife Corporation
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients referred to a hypertensive clinic for primary hypertension. (This means that subjects can also be normotensive after extended diagnosis).

Exclusion criteria

Exclusion criteria: Patients with uncontrolled primary or secondary causes of hypertension. Patients with unstable angina, myocardial infarction, transient ischemic attack or stroke within the past 3 months.

Design outcomes

Primary

MeasureTime frame
Blood pressure measurement values and feasibility as determined by questionnaires filled out by both physicians and subjects.—

Secondary

MeasureTime frame
Not applicable.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)